We are live on ! Find out more
TECH icon

Bio-Techne

577 hedge funds and large institutions have $8.84B invested in Bio-Techne in 2025 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 214 increasing their positions, 185 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $29.5M | Put options by funds: $20.3M

39% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 70

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

16% more repeat investments, than reductions

Existing positions increased: 214 | Existing positions reduced: 185

8% more capital invested

Capital invested by funds: $8.16B → $8.84B (+$677M)

4% more funds holding

Funds holding: 556577 (+21)

0.87% more ownership

Funds ownership: 101.2%102.07% (+0.87%)

Holders
577
Holders Change
+21
Holders Change %
+3.78%
% of All Funds
7.55%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
97
Increased
214
Reduced
185
Closed
70
Calls
$29.5M
Puts
$20.3M
Net Calls
+$9.27M
Net Calls Change
+$946K

TECH Hedge Fund Activity: Q3 2025 in Review

577 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2025, worth a combined $8.84B — up 8.3% from $8.16B a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new TECH positions and 70 closed out — a net gain of 27 holders — while 214 added to existing stakes and 185 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $213M. The largest seller was T. Rowe Price Associates, cutting an estimated $294M.

  • 577 institutional investors held Bio-Techne (TECH) as of Q3 2025, up from 556 in Q2 2025.
  • Funds reported $8.84B of Bio-Techne stock for Q3 2025, up 8.3% quarter-over-quarter.
  • 97 funds opened new Bio-Techne positions in Q3 2025 and 70 closed out, a net change of +27 holders.
  • The largest Bio-Techne buyer in Q3 2025 was Wellington Management Group, an estimated $213M added.
  • The largest Bio-Techne seller in Q3 2025 was T. Rowe Price Associates, an estimated $294M sold.

Based on aggregated 13F filings for Q3 2025.